source
- FDA approves Orca Bio's T-cell therapy to lower graft-versus-host disease risk in blood cancer transplantsThe FDA gave its nod to Orca Bio's personalized T-cell therapy, Tregzi, aimed at patients with blood cancers undergoing stem cell transplants. The therapy is designed to cut the chance of chronic…
- Study finds statins and blood-pressure meds bring middle-aged obese adults' heart risk markers in line with normal-weight peersA new 25-year observational study published in The Lancet shows that adults over 40 with obesity have blood‑pressure and cholesterol levels comparable to those of normal‑weight individuals. Resear…